Figure 8.

Immune infiltration and drug sensitivity analysis of MAS1L. Notes: (a) the CIBERSORT algorithm was used to quantify the immune infiltration of cancer tissue; (b) the patients with high MAS1L might have a lower M2 macrophages infiltration; (c–f) the correlation of riskscore and mast cells, eosinophil, iDC, and Th2 cells; (g–j) the correlation of riskscore and the IC50 of Gemcitabine, Docetaxel, Paclitaxel, and Cisplatin.